Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual
Landmark licensing deal with Takeda for fruquintinib outside of China, bringing HUTCHMED up to US$1.13 billion, plus royalties, and demonstrating execution of the new global strategy Record Full Year
/PRNewswire/ The "Blow Fill Seal Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 By Raw Material (LDPE, PP &.